It is an innovative strategy, in the evaluation phase, which offers a more early and accurate therapeutic option against some tumors with a poor prognosis. The Functional Unit of Neurooncology HUB...
Read moreThe first systematic study of its kind describes how human viruses including SARS-CoV-2 are better adapted to infecting certain types of tissues based on their ability to hijack cellular machinery ...
Read more Investigadores del Instituto de Investigación Sanitaria Biodonostia pertenecientes al Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), acaban de p...
Read moreLa empresa biofarmacéutica GenSight Biologics, especializada en el desarrollo de terapias génicas para enfermedades degenerativas de la retina, ha publicado recientemente los resultados de dos ensay...
Read moreEl IBSAL adquiere un equipamiento que permitirá producir células CAR-T y purificar y expandir otras poblaciones celulares para uso clínico en un sistema cerrado
Read moreEl Hospital General Universitario Gregorio Marañón acaba de dar de alta a Binta, una niña de tan sólo 7 años que ha sido trasplantada de medula ósea por anemia falciforme. Con este trasplante, e...
Read more Investigadores de la Universidad de California San Diego han desarrollado una estrategia de terapia génica que permite regular la tolerancia al dolor a través del control de un gen implicado ...
Read moreThe companies will combine their advanced technologies to provide an individualized vaccine design for patients with no treatment options
Read moreSpain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of diseases such as cancer, where 62% of clinical trials are conducted.
Read moreThe researchers conducted an in-depth study of resistance to temozolomide, the first-line treatment for glioblastoma, to which many patients cease to respond over time
Read moreSe trata de ViroTCell, un fármaco de terapia avanzada dirigido a tratar las infecciones por citomegalovirus que se pueden desarrollar en el marco de los trasplantes de progenitores de médula ósea.
Read more Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Vivet Therapeutics (“Vivet”) announced today an agreement whereby Mirum has the exclusive option to develop and subsequently commercialize Viv...
Read more